Filing Details

Accession Number:
0001494650-18-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-11 17:12:27
Reporting Period:
2018-06-07
Accepted Time:
2018-06-11 17:12:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1494650 Optinose Inc. OPTN Pharmaceutical Preparations (2834) 421771610
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685002 P Robert O'neil C/O Optinose, Inc.
1020 Stony Hill Road, Suite 300
Yardley PA 19067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-08 2,000 $22.75 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-06-07 28,879 $22.50 28,879 $22.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,879 2028-06-06 No 4 A Direct
Footnotes
  1. The option vests and becomes exercisable over a three-year period commencing on June 7, 2018. Thirty-three percent (33%) of the option vests and becomes exercisable on June 7, 2019, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer.